CENTAURUS FINANCIAL, INC. - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
CENTAURUS FINANCIAL, INC. ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$1,830
+82.3%
67,998
+104.0%
0.16%
+80.7%
Q2 2023$1,004
-49.9%
33,332
-46.1%
0.09%
-45.0%
Q1 2023$2,002
+16.0%
61,885
+2.8%
0.16%
-1.2%
Q4 2022$1,726
-98.9%
60,228
+798.4%
0.16%
+912.5%
Q3 2022$162,000
-17.3%
6,704
+31.0%
0.02%
+6.7%
Q1 2022$196,000
+17.4%
5,118
-2.1%
0.02%
+15.4%
Q4 2021$167,000
+2.5%
5,226
-5.4%
0.01%
-7.1%
Q3 2021$163,000
-73.3%
5,526
-69.3%
0.01%
-72.5%
Q2 2021$611,000
+86.3%
17,994
+78.1%
0.05%
+59.4%
Q1 2021$328,000
-83.0%
10,104
-81.1%
0.03%
-84.2%
Q4 2020$1,926,000
+297.1%
53,462
+331.3%
0.20%
+203.0%
Q3 2020$485,000
-70.4%
12,395
-72.3%
0.07%
-72.4%
Q2 2020$1,641,000
+68.8%
44,736
+6.0%
0.24%
+25.3%
Q1 2020$972,000
+54.8%
42,185
+96.6%
0.19%
+120.5%
Q4 2019$628,000
-8.9%
21,455
-16.9%
0.09%
-18.5%
Q3 2019$689,000
-70.8%
25,814
-72.0%
0.11%
-70.9%
Q2 2019$2,358,000
-98.0%
92,255
+3433.3%
0.37%
-45.8%
Q1 2019$116,470,000
+106753.2%
2,611
+13.6%
0.68%
-12.4%
Q4 2018$109,000
-4.4%
2,298
-54.9%
0.78%
+4787.5%
Q2 2018$114,0005,0920.02%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders